These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19350273)

  • 1. High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.
    Hu J; Xu Y; Shen ZZ; Wang Z; Lu Q; Yang GH; Ding ZB; Fan J; Zhou J
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1359-67. PubMed ID: 19350273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
    Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
    World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    BMC Cancer; 2013 Jun; 13():306. PubMed ID: 23800357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.
    Zhou J; Tang ZY; Fan J; Wu ZQ; Li XM; Liu YK; Liu F; Sun HC; Ye SL
    J Cancer Res Clin Oncol; 2000 Jan; 126(1):57-61. PubMed ID: 10641751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis.
    Guo L; Kuroda N; Toi M; Miyazaki E; Hayashi Y; Enzan H; Jin Y
    Oncol Rep; 2001; 8(4):871-6. PubMed ID: 11410801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection.
    Minata M; Harada KH; Kudo M; Ikai I; Nishida N
    Oncology; 2013; 84 Suppl 1():75-81. PubMed ID: 23428863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.
    Tamura Y; Igarashi M; Suda T; Wakai T; Shirai Y; Umemura T; Tanaka E; Kakizaki S; Takagi H; Hiasa Y; Onji M; Aoyagi Y
    Dig Dis Sci; 2010 Jul; 55(7):2095-101. PubMed ID: 19731025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma.
    Kaio E; Tanaka S; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
    Oncology; 2003; 64(1):61-73. PubMed ID: 12457033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
    Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study.
    Wang ZL; Liang P; Dong BW; Yu XL; Yu DJ
    J Gastrointest Surg; 2008 Feb; 12(2):327-37. PubMed ID: 17943391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
    Yin X; Li YW; Zhang BH; Ren ZG; Qiu SJ; Yi Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.
    Zhu W; Guo L; Zhang B; Lou L; Lin Z; Zhu X; Ren N; Dong Q; Ye Q; Qin L
    Ann Surg Oncol; 2014 Apr; 21(4):1304-13. PubMed ID: 24366422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Lin K; Huang Q; Zeng J; Ding Z; Wang L; Chen Z; Guo P; Zeng Y; Zhou W; Liu J
    Dig Dis Sci; 2021 Dec; 66(12):4545-4556. PubMed ID: 33723698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.
    Ding HF; Zhang XF; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):660-666. PubMed ID: 33082065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived endothelial cell growth factor (PD-ECGF) is up-regulated in human hepatocellular carcinoma (HCC) and the corresponding hepatitis liver.
    Morinaga S; Yamamoto Y; Noguchi Y; Imada T; Rino Y; Akaike M; Sugimasa Y; Takemiya S; Takanashi Y
    Hepatogastroenterology; 2003; 50(53):1521-6. PubMed ID: 14571777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
    Chen L; Shi Y; Jiang CY; Wei LX; Lv YL; Wang YL; Dai GH
    Int J Biol Markers; 2011; 26(2):108-16. PubMed ID: 21574155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.